Conexeu Sciences Inc. (CNXU)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	198.46M
Revenue (ttm)	n/a
Net Income	-3.92M
EPS	-0.20
Shares Out	19.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CNXU

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property developed over more than a decade at the University of British Columbia and the BC Professional Firefighters Burn and Wound Healing Laboratory. The Company's only device candidate is the CXU™ scaffold device candidate. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound c...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2022
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: CNXU
• Website: https://conexeu.com/